Clinical Trials for AMO Pharma

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AMO Pharma

Clinical Trials (2)

NCT06174220
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
PHASE2Recruiting
120 participants
Started: Mar 21, 2025 · Completed: Jul 1, 2027
2 conditions6 sponsors17 locations
NCT05004129
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
PHASE2/PHASE3Recruiting
76 participants
Started: Aug 23, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor14 locations